Longevity and wellness clinics that run TRT, ketamine, semaglutide, or IV hydration protocols need a physician who understands hormone and peptide medicine, not a collaborating agreement borrowed from a Botox practice. This guide breaks down what a medical director for longevity clinics actually has to cover in 2026, who should hire one, and which arrangement fits your service mix.
- A medical director for longevity clinics must sign off on hormone, peptide, and IV protocols specifically — verify vertical experience before you sign.
- Clinics running TRT, ketamine, and semaglutide together need one director who covers all three, not three separate contracts.
- Chart review cadence of every 10 to 14 days is standard for hormone and peptide protocols — anything looser is a Skip.
- A director with no telehealth or multi-state coverage is a Skip for clinics running virtual hormone consults across state lines.
- Bulk collaborating physician plans through US Medical Directors lower per-provider cost for multi-location longevity groups — Consider if you run more than one site.
Why this matters
Longevity medicine sits in a regulatory gray zone that standard med spa oversight doesn't cover. A director who signs off on Botox and filler doesn't automatically know how to review a TRT titration schedule or a semaglutide dosing ladder, and most state boards expect protocol-specific competency, not a generic signature.
If your clinic offers hormone therapy and TRT alongside IV hydration or peptide work, the oversight structure has to match the actual services on your menu. Getting this wrong in 2026 means a chart review process that misses the exact protocols regulators are watching closest this year.
US Medical Directors places physicians who oversee these specific verticals across dozens of states, which matters more for longevity clinics than for a single-service med spa because the liability exposure spans several protocol types at once.
Who this is for
This guide is for owners of wellness and longevity clinics running two or more of the following: TRT and hormone optimization, ketamine therapy, semaglutide or other GLP-1 weight-loss programs, IV hydration or mobile IV services, and peptide or PRP protocols. It also applies to nurse practitioners and PAs operating under state supervision requirements who need a collaborating physician who actually understands these protocols, not just the paperwork.
What to look for in a medical director for longevity clinics
Vertical-specific protocol experience
A director who has only ever reviewed injectable aesthetics charts will not catch a dosing error in a TRT titration schedule. Ask for direct experience with the specific verticals on your service menu before signing anything.
Multi-state or telehealth coverage
Longevity clinics increasingly run virtual consults for hormone therapy and weight-loss management across state lines. A director licensed in one state only becomes a liability the moment a telehealth patient logs in from a neighboring state.
Chart review cadence and documentation
Most collaborating agreements for hormone and peptide protocols call for chart review every 10 to 14 days, tighter than the monthly cadence common in general aesthetics. Anything looser leaves gaps between prescribing decisions and physician sign-off.
Good faith exam turnaround
Semaglutide, TRT, and ketamine patients typically need a documented good faith exam before the first protocol visit. A director who takes weeks to schedule this stalls onboarding for every new patient your clinic brings in.
Liability coverage structure
Hormone and peptide oversight carries different malpractice exposure than filler injections. Confirm how liability coverage is structured for the specific protocols the director is signing off on, not just a blanket aesthetics policy.
Pricing transparency for multi-vertical coverage
Most directors price per service line, so a clinic running TRT, IV therapy, and semaglutide together can end up paying three separate retainer fees. Ask upfront whether one contract can cover multiple verticals at a bundled rate.
Get Matched With a Longevity Clinic Director
Physicians who cover hormone, peptide, and IV protocols across most states.
Top picks by service line
Hormone therapy and TRT oversight — the specialist pick
Hormone optimization protocols need chart review tied to lab values, not just a signature. A director experienced in hormone therapy oversight reviews titration schedules alongside bloodwork, which is the single most common gap boards flag in 2026 audits. Buy if TRT or hormone optimization is a core service line.
IV hydration and mobile IV therapy — the volume pick
Mobile IV businesses run high patient volume with fast turnover, so oversight needs to scale without slowing intake. A director set up for IV hydration and mobile IV therapy structures chart review around batch protocols instead of one-off sign-offs. Buy for clinics doing more than a handful of IV visits per week.
Ketamine therapy clinics — the tightest oversight pick
Ketamine protocols carry the strictest monitoring requirements of any longevity service, including session-by-session vitals review. A director versed in ketamine therapy oversight knows the documentation standard boards expect at every dosing increase. Buy — this is the vertical where a generalist director creates the most exposure.
Semaglutide and GLP-1 weight-loss programs — the fastest-growing pick
GLP-1 patient volume has scaled faster than most clinics' oversight infrastructure, and the good faith exam requirement for semaglutide clinics is where new patients get stuck waiting on sign-off. Consider a director who batches these exams weekly rather than one-off, since intake volume in this vertical keeps climbing through 2026.
PRP and peptide hair restoration — the niche add-on
PRP and peptide hair protocols are lower-liability but still need a documented exam before treatment starts. Consider this vertical as an add-on to an existing hormone or IV contract rather than a standalone director relationship, since volume rarely justifies a separate retainer.
What to avoid
- A single-vertical director covering a multi-vertical clinic. A director who only knows aesthetics injectables and gets handed a TRT chart to sign off on is a compliance risk, not a cost saver.
- No telehealth coverage for a clinic running virtual consults. If any portion of your patient base logs in from outside your primary state, single-state coverage leaves those visits unsupervised.
- Flat-fee contracts with no chart review cadence specified. A low retainer with vague or undefined review frequency usually means the director isn't actually reviewing anything on a schedule.
Verdict comparison
| Service line | Primary oversight need | Typical review cadence | Verdict |
|---|---|---|---|
| Hormone therapy / TRT | Lab-tied titration review | Every 10-14 days | Buy |
| IV hydration / mobile IV | Batch protocol sign-off | Weekly | Buy |
| Ketamine therapy | Session-level vitals monitoring | Per session | Buy |
| Semaglutide / GLP-1 | Good faith exam turnaround | Before first visit, then monthly | Consider |
| PRP / peptide hair restoration | Pre-treatment exam only | Per treatment cycle | Consider |
FAQ
What does a medical director for longevity clinics do?
A medical director for longevity clinics reviews and signs off on protocols for hormone therapy, peptides, IV hydration, ketamine, or weight-loss programs, and conducts or delegates good faith exams before treatment starts. In most states this role also covers ongoing chart review to confirm the clinic is following documented protocols.
How much does a medical director cost for a wellness clinic in 2026?
Cost varies by state, patient volume, and how many service lines need coverage, since a clinic running TRT, IV therapy, and semaglutide together typically needs broader oversight than a single-service practice. Bulk or multi-vertical contracts usually bring the per-service cost down compared to separate retainers.
Can one medical director cover TRT, ketamine, and IV hydration at the same clinic?
Yes, as long as the director has documented experience in each of those specific protocols rather than general aesthetics oversight. Ask for a breakdown of how chart review differs across the three service lines before signing.
Do longevity clinics need good faith exams for semaglutide patients?
Most states require a documented good faith exam before a semaglutide or GLP-1 protocol begins, similar to the exam requirement for injectable aesthetics. The exam needs to happen before the first dose, not after.
Is a collaborating physician the same as a medical director?
The terms overlap but aren’t identical — a collaborating physician typically supervises a specific nurse practitioner or PA under a state-defined agreement, while a medical director oversees clinic-wide protocols and chart review. Many longevity clinics need both roles filled, sometimes by the same physician.
How often should a medical director review charts for a longevity clinic?
Hormone and peptide protocols typically call for chart review every 10 to 14 days, tighter than the monthly cadence common in general aesthetics. Ketamine protocols often need review at the session level given the tighter monitoring requirements.
Can a telehealth longevity clinic use one medical director across multiple states?
Only if the director holds licensure or a compliant collaborating arrangement in every state where patients are located during their telehealth visit. A single-state director covering multi-state telehealth patients creates unsupervised visits in every state outside their license.
What happens if a longevity clinic operates without medical director oversight?
Operating without documented physician oversight exposes the clinic to state board action and voids most malpractice coverage tied to protocol-based treatments like TRT or ketamine therapy. Boards in 2026 are specifically flagging clinics that lack chart-level sign-off on hormone and peptide protocols.
One last thing
Most complaints filed against longevity clinics don't trace back to injection technique or dosing error — they trace back to a missing sign-off between the prescribing decision and the chart review that was supposed to catch it. A documented, on-schedule chart review process is the cheapest insurance a longevity clinic can buy against a board complaint in 2026.
Related guides
